Profile picture

Doctor Joana Brito

Santa Maria University Hospital CHLN Lisbon Academic Medical Centre, Lisbon (Portugal)
Membership: ESC Professional Member
Follow
Logo ESC

Contributor content

Atypical flutter: effectiveness of a systematic strategy based on comprehensive high-density map analysis
Presentation
Atypical flutter: effectiveness of a systematic strategy based on comprehensive high-density map analysis
Read more
Biatrial flutters: unique circuits requiring a customized ablation approach
Presentation
Biatrial flutters: unique circuits requiring a customized ablation approach
Read more
Is there still a role for neurohormonal therapy in patients with STEMI and mildly reduced ejection
Presentation
Is there still a role for neurohormonal therapy in patients with STEMI and mildly reduced ejection
Read more
Levosimendan - single center experience in chronic HF
Presentation
Levosimendan - single center experience in chronic HF
Read more
Sodium-glucose cotransporter 2 inhibitors in patients with transthyretin amyloid cardiomyopathy - results from a patient series
Presentation
Sodium-glucose cotransporter 2 inhibitors in patients with transthyretin amyloid cardiomyopathy - results from a patient series
Read more
Late potentials assessment - an useful tool for Brugada Syndrome risk stratification
Presentation
Late potentials assessment - an useful tool for Brugada Syndrome risk stratification
Read more
Spontaneous left-sided atypical flutter: revising the mechanisms in patients not submitted to prior linear ablation
Presentation
Spontaneous left-sided atypical flutter: revising the mechanisms in patients not submitted to prior linear ablation
Read more
Brugada syndrome in Portugal: a cohort characterization
Presentation
Brugada syndrome in Portugal: a cohort characterization
Read more
SGLT2 inhibition in acute myocardial infarction with left ventricular systolic dysfunction
Presentation
SGLT2 inhibition in acute myocardial infarction with left ventricular systolic dysfunction
Read more
Main limiting factors of foundational therapy introduction in patients with heart failure with reduced ejection fraction
Presentation
Main limiting factors of foundational therapy introduction in patients with heart failure with reduced ejection fraction
Read more

ESC 365 is supported by

novartis Explore sponsored resources